技术文章

Applications of Endocrinology/Hormones in Metabolic Regulation, Reproductive Function, and Disease Research

The endocrine system maintains body homeostasis through hormone secretion, target organ responses, and feedback regulation. Hormones regulate glucose and lipid metabolism, growth and development, reproductive function, stress responses, water and electrolyte balance, bone metabolism, and energy homeostasis. They are important research objects in diabetes, thyroid diseases, reproductive endocrine disorders, adrenal diseases, and hormone-dependent tumors.

 

Keywords: endocrinology; hormones; insulin; thyroid hormone; steroid hormone; sex hormone; HPA axis; GPCR

 

1 Hormone Types and Functional Characteristics

1.1 Peptide and Protein Hormones

Peptide and protein hormones are usually secreted after precursor protein processing. They are highly water-soluble and mainly act through cell membrane receptors. Insulin, glucagon, ACTH, TSH, LH, FSH, GH, PRL, PTH, GLP-1, GIP, leptin, and adiponectin all belong to this category. These hormones often activate signaling branches such as cAMP, Ca²⁺, PI3K/AKT, MAPK, and STAT through GPCRs, receptor tyrosine kinases, or JAK/STAT-related receptors.

 

1.2 Steroid Hormones

Steroid hormones are derived from cholesterol and include glucocorticoids, mineralocorticoids, estrogens, progestogens, and androgens. These hormones are highly lipid-soluble and can enter cells to bind nuclear receptors or cytoplasmic receptors, thereby regulating target gene transcription. They can also produce rapid effects through non-genomic mechanisms. Steroid hormone research should focus on total hormone, free hormone, binding proteins, metabolic enzymes, and receptor expression.

 

1.3 Amino Acid-Derived Hormones

Thyroid hormones, catecholamines, and melatonin are amino acid-derived hormones. T3/T4 mainly regulate basal metabolism and development through thyroid hormone receptors. Epinephrine, norepinephrine, and dopamine participate in stress, cardiovascular, and neuroendocrine responses through adrenergic receptors or dopamine receptors. Melatonin is associated with circadian rhythm, sleep, and oxidative stress regulation.

 

1.4 Vitamin D and Local Hormone-Like Molecules

Vitamin D is metabolized by the liver and kidney to form active calcitriol, which regulates calcium-phosphate homeostasis, bone metabolism, and immune function through the vitamin D receptor (VDR). Lipid-derived molecules such as prostaglandins, leukotrienes, and endocannabinoids have local hormone-like effects and often intersect with inflammation, vascular responses, and metabolic regulation.

 

Table 1 Hormone Types and Functional Characteristics

 

Hormone Type

Representative Members

Main Receptor Types

Main Actions

Common Research Directions

Peptide/protein hormones

Insulin, glucagon, TSH, LH, FSH, GH, GLP-1, PTH

GPCRs, RTKs, JAK/STAT-related receptors

Rapid secretion and membrane receptor-mediated effects

Glucose metabolism, reproductive axis, pituitary function, calcium-phosphate metabolism

Steroid hormones

Cortisol, aldosterone, estradiol, progesterone, testosterone

Nuclear receptors, some membrane-associated receptors

Strong transcriptional regulation and tissue specificity

Stress, reproduction, inflammation, hormone-dependent tumors

Amino acid-derived hormones

T3, T4, epinephrine, norepinephrine, dopamine, melatonin

Nuclear receptors, GPCRs

Metabolism, stress, rhythm regulation

Thyroid function, sympathetic-adrenal system, circadian rhythm

Vitamin D axis-related molecules

Cholecalciferol, calcitriol

VDR

Calcium-phosphate homeostasis, bone metabolism, immune regulation

Osteoporosis, chronic kidney disease, immunometabolism

 

2 Major Endocrine Axes and Regulatory Networks

2.1 Hypothalamic-Pituitary-Thyroid Axis

The hypothalamus secretes TRH, which promotes pituitary release of TSH. TSH acts on the thyroid gland and promotes the synthesis and release of T3/T4. Increased T3/T4 can inhibit TRH and TSH through negative feedback. This axis mainly regulates basal metabolism, body temperature, neural development, cardiovascular function, and energy expenditure.

 

2.2 Hypothalamic-Pituitary-Adrenal Axis

The HPA axis consists of CRH, ACTH, and cortisol, and is an important system for stress responses, glucose metabolism, and inflammatory regulation. Cortisol has a clear circadian rhythm, so sampling time must be considered during detection and interpretation. Aldosterone mainly participates in water and electrolyte balance, blood pressure regulation, and cardiac-renal remodeling.

 

2.3 Hypothalamic-Pituitary-Gonadal Axis

The HPG axis consists of GnRH, LH, FSH, and gonadal hormones. It regulates follicular development, ovulation, luteal function, spermatogenesis, pregnancy maintenance, and development of secondary sexual characteristics. Estrogen, progesterone, testosterone, AMH, inhibin, and prolactin are commonly used to evaluate reproductive endocrine function.

 

2.4 Islet-Incretin-Adipokine Network

Insulin, glucagon, GLP-1, GIP, leptin, adiponectin, and FGF21 jointly regulate blood glucose, lipid metabolism, appetite, energy expenditure, and pancreatic β-cell function. Research on diabetes, obesity, fatty liver, and metabolic syndrome usually requires simultaneous analysis of islet function, insulin sensitivity, and adipose tissue endocrine status.

 

2.5 Calcium-Phosphate Metabolism Axis

PTH, vitamin D, calcitonin, and FGF23 jointly regulate blood calcium, blood phosphorus, bone remodeling, and renal reabsorption. This axis is closely associated with osteoporosis, chronic kidney disease-mineral and bone disorder, parathyroid dysfunction, and vitamin D deficiency.

 

Table 2 Major Endocrine Axes and Detection Indicators

 

Endocrine Axis

Representative Hormones

Main Functions

Common Detection

HPT axis

TRH, TSH, T3, T4

Basal metabolism, neural development, cardiovascular function

TSH, FT4, FT3, TPOAb, TgAb, TRAb

HPA axis

CRH, ACTH, cortisol, DHEA-S

Stress, inflammation, glucose metabolism, and immune regulation

ACTH, cortisol, DHEA-S

HPG axis

GnRH, LH, FSH, E2, P4, testosterone

Reproduction, gonadal function, and pubertal development

LH, FSH, E2, P4, Testosterone, AMH

Islet metabolic axis

Insulin, glucagon, GLP-1, GIP

Glucose and lipid metabolism, islet function, and energy homeostasis

Insulin, C-peptide, blood glucose, GLP-1, GIP

Adipokine network

Leptin, adiponectin, resistin, FGF21

Adipose tissue endocrinology, inflammation, and insulin sensitivity

Leptin, adiponectin, LAR, FGF21

Calcium-phosphate metabolism axis

PTH, vitamin D, calcitonin, FGF23

Calcium-phosphate homeostasis and bone metabolism

PTH, 25(OH)D, blood calcium, blood phosphorus, FGF23

 

3 Hormone Receptors and Downstream Signaling

3.1 GPCR-Mediated Hormone Signaling

ACTH, TSH, LH, FSH, GLP-1, glucagon, PTH, catecholamines, and other hormones can act through GPCRs. GPCRs regulate branches such as cAMP/PKA, Ca²⁺/PKC, MAPK, and RhoA/ROCK through G proteins including Gs, Gi/o, Gq/11, and G12/13, thereby affecting secretion, metabolism, contraction, and cellular function.

 

3.2 RTK and PI3K/AKT Signaling

Insulin and IGF-1 mainly activate PI3K/AKT and MAPK branches through receptor tyrosine kinases. After insulin stimulation, p-IR, p-IRS, p-AKT, GLUT4 translocation, and glucose uptake are commonly detected to evaluate insulin sensitivity and metabolic response.

 

3.3 JAK/STAT-Related Hormone Signaling

GH, PRL, leptin, and related hormones regulate target gene expression through JAK/STAT-related mechanisms. GH often affects growth and metabolism through JAK2/STAT5, while leptin often affects appetite, energy expenditure, and inflammatory status through JAK2/STAT3.

 

3.4 Nuclear Receptor-Mediated Transcriptional Regulation

Estrogens, progesterone, androgens, glucocorticoids, mineralocorticoids, thyroid hormones, and vitamin D mainly regulate transcription through nuclear receptors. Nuclear receptor effects depend not only on hormone concentration, but also on receptor expression, coactivators, corepressors, chromatin state, and tissue context.

 

Table 3 Hormone Receptor Types and Research Indicators

 

Receptor Type

Representative Hormones

Main Signaling

Common Detection

GPCR

ACTH, TSH, LH, FSH, GLP-1, PTH, catecholamines

cAMP/PKA, Ca²⁺/PKC, MAPK

cAMP, p-CREB, Ca²⁺ imaging, p-ERK

RTK

Insulin, IGF-1

PI3K/AKT, MAPK

p-IR, p-IRS, p-AKT, GLUT4

JAK/STAT-related receptors

GH, PRL, leptin

JAK2/STAT3, JAK2/STAT5

p-STAT3, p-STAT5, SOCS-related molecules

Nuclear receptors

Estrogens, progesterone, androgens, glucocorticoids, mineralocorticoids, thyroid hormones, and vitamin D

Transcriptional regulation, chromatin remodeling

Receptor nuclear localization, target genes, reporter genes

Membrane-associated steroid receptors

Some estrogens, progestogens, and glucocorticoids

MAPK, PI3K, Ca²⁺

Rapid phosphorylation, Ca²⁺ changes, membrane receptor expression

 

4 Endocrine Diseases and Research Focuses

4.1 Diabetes and Metabolic Syndrome

Research on diabetes and metabolic syndrome should focus on pancreatic β-cell function, insulin resistance, hepatic glucose output, adipose tissue inflammation, and incretin function. Insulin, C-peptide, glucagon, GLP-1, GIP, leptin, and adiponectin are commonly used indicators. Increased insulin can suggest compensatory insulin resistance, but if accompanied by decreased C-peptide and hyperglycemia, it may reflect insufficient β-cell secretory capacity.

 

4.2 Thyroid Diseases

Thyroid diseases include hyperthyroidism, hypothyroidism, autoimmune thyroiditis, and thyroid nodule-related abnormalities. TSH, FT4, FT3, and thyroid autoantibodies are the core detection panel. Elevated TSH with decreased FT4 supports primary hypothyroidism, while decreased TSH with elevated FT4/FT3 supports hyperthyroidism. If TSH does not match peripheral hormones, pituitary factors, drug effects, or assay interference should be considered.

 

4.3 Reproductive Endocrine Disorders

Reproductive endocrine disorders involve polycystic ovary syndrome, decreased ovarian reserve, male hypogonadism, infertility, and abnormal pubertal development. Female sex hormone testing should specify the menstrual cycle stage. Male testosterone testing usually prioritizes morning samples and should be interpreted together with SHBG and free testosterone.

 

4.4 Adrenal Diseases and Stress Abnormalities

Adrenal diseases include Cushing’s syndrome, adrenal insufficiency, primary aldosteronism, and pheochromocytoma-related abnormalities. ACTH, cortisol, aldosterone, renin, and catecholamine-related indicators are strongly affected by stress, body position, medications, and sampling time, so interpretation should be combined with dynamic tests or repeated sampling.

 

4.5 Bone Metabolism and Calcium-Phosphate Homeostasis Abnormalities

Osteoporosis, chronic kidney disease-mineral and bone disorder, and parathyroid diseases are closely associated with PTH, vitamin D, calcitonin, FGF23, sex hormones, and thyroid hormones. Bone metabolism research should integrate blood calcium, blood phosphorus, 25(OH)D, PTH, and bone turnover markers.

 

Table 4 Endocrine Diseases and Common Hormone Indicators

 

Disease Direction

Key Hormones

Main Mechanism

Common Detection

Diabetes and insulin resistance

Insulin, C-peptide, glucagon, GLP-1, adiponectin, leptin

Pancreatic β-cell function, insulin sensitivity, adipose tissue function

Blood glucose, insulin, C-peptide, HbA1c, HOMA-IR

Thyroid diseases

TSH, T3, T4, thyroid antibodies

HPT axis feedback and autoimmunity

TSH, FT4, FT3, TPOAb, TRAb

Reproductive endocrine disorders

LH, FSH, E2, P4, Testosterone, AMH

HPG axis abnormalities and gonadal function changes

LH, FSH, sex hormones, AMH, PRL

Adrenal diseases

ACTH, cortisol, aldosterone, catecholamines

Stress response, mineralocorticoids, and sympathetic-adrenal system abnormalities

ACTH, cortisol, ARR, urine/saliva indicators

Bone metabolism abnormalities

PTH, vitamin D, calcitonin, FGF23

Calcium-phosphate homeostasis, bone remodeling, and renal regulation

PTH, 25(OH)D, blood calcium, blood phosphorus, bone turnover markers

Obesity and energy metabolism abnormalities

Leptin, adiponectin, ghrelin, FGF21

Appetite, adipose tissue function, energy expenditure

Leptin, adiponectin, LAR, FGF21, blood lipids

 

5 Representative Products Related to Endocrinology and Hormone Research

 

Research Module

Representative Product

CAS No.

Mechanism or Detection Positioning

Applicable Research

Insulin signaling research

Human insulin

11061-68-0

Insulin receptor agonist that activates the PI3K/AKT pathway

GLUT4 translocation, p-AKT, glucose uptake, and insulin sensitivity research

Glucagon signaling research

Glucagon

16941-32-5

Glucagon receptor ligand

Hepatic glycogenolysis, gluconeogenesis, cAMP signaling, and blood glucose regulation research

Diabetes model construction

Streptozotocin

18883-66-4

Pancreatic β-cell damaging agent

Type 1 diabetes models, islet injury, and hypoglycemic drug evaluation

Insulin resistance model

Palmitic acid

57-10-3

Saturated fatty acid that induces lipotoxicity and insulin resistance

Insulin resistance models in hepatocytes, adipocytes, and muscle cells

Metabolic stress research

Metformin hydrochloride

1115-70-4

AMPK-related metabolic regulatory drug

Diabetes, AMPK, autophagy, hepatic glucose output, and insulin sensitivity research

Thyroid hormone research

L-Thyroxine (T4)

51-48-9

Thyroid hormone receptor ligand

Basal metabolism, thyroid function, development, and energy expenditure research

Thyroid hormone research

Triiodothyronine (T3)

6893-02-3

Active thyroid hormone

Thyroid hormone receptor signaling, metabolic regulation, and target gene expression research

Glucocorticoid research

Cortisol

50-23-7

Glucocorticoid receptor ligand

HPA axis, stress, anti-inflammatory responses, and glucose metabolism research

Glucocorticoid intervention

Dexamethasone

50-02-2

Glucocorticoid receptor agonist

Anti-inflammatory responses, adipogenic/osteogenic differentiation, insulin resistance, and stress model research

Mineralocorticoid research

Aldosterone

52-39-1

Mineralocorticoid receptor ligand

Water-electrolyte balance, blood pressure regulation, renal reabsorption, and cardiovascular remodeling research

Sex hormone research

17β-Estradiol

50-28-2

Estrogen receptor ligand

ERα/ERβ signaling, bone metabolism, reproductive endocrinology, and breast cancer research

Sex hormone research

Estrone

53-16-7

Estrogenic molecule

Estrogen metabolism, menopause-related endocrinology, and hormone-dependent disease research

Sex hormone research

Progesterone

57-83-0

Progesterone receptor ligand

Endometrium, luteal function, pregnancy maintenance, and PR signaling research

Adrenal androgen research

Dehydroepiandrosterone

53-43-0

Adrenal-derived androgen precursor

Adrenal function, sex hormone synthesis, and aging-related endocrine research

Catecholamine research

Dopamine hydrochloride

62-31-7

Dopamine receptor ligand

Neuroendocrinology, stress responses, and catecholamine signaling research

Catecholamine research

Norepinephrine bitartrate

69815-49-2

α/β-adrenergic receptor ligand

Sympathetic-adrenal system, vascular responses, and stress model research

Catecholamine research

Epinephrine bitartrate

51-42-3

α/β-adrenergic receptor agonist

Cardiovascular responses, stress hormone signaling, and metabolic mobilization research

Circadian rhythm hormone research

Melatonin

73-31-4

Pineal gland-derived rhythmic hormone

Sleep rhythm, oxidative stress, neuroendocrinology, and light-cycle rhythm research

Vitamin D axis research

Cholecalciferol

67-97-0

Vitamin D3 precursor

Vitamin D metabolism, calcium-phosphate homeostasis, and bone metabolism research

Vitamin D axis research

Calcitriol

32222-06-3

Active vitamin D

VDR signaling, calcium-phosphate metabolism, bone formation, and immune regulation research

Estrogen receptor regulation

Tamoxifen citrate

54965-24-1

Selective estrogen receptor modulator

ER-positive breast cancer, estrogen-dependent proliferation, and endocrine therapy research

Estrogen receptor regulation

Fulvestrant

129453-61-8

Estrogen receptor degrader/antagonist

ER signaling blockade, breast cancer resistance, and nuclear receptor pharmacodynamics research

Androgen receptor regulation

Flutamide

13311-84-7

Androgen receptor antagonist

AR signaling, prostate cancer, and androgen-dependent growth research

Androgen receptor regulation

Bicalutamide

90357-06-5

Androgen receptor antagonist

AR pathway inhibition, prostate cancer models, and resistance mechanism research

Progesterone/glucocorticoid receptor regulation

Mifepristone

84371-65-3

Progesterone receptor and glucocorticoid receptor antagonist

PR/GR signaling, reproductive endocrinology, and cortisol-related disease research

Mineralocorticoid receptor regulation

Spironolactone

52-01-7

Mineralocorticoid receptor antagonist

Aldosterone signaling, hypertension, cardiac-renal remodeling, and water-electrolyte metabolism research

Mineralocorticoid receptor regulation

Eplerenone

107724-20-9

Selective mineralocorticoid receptor antagonist

MR signaling, cardiovascular remodeling, and renal protection research

GPCR hormone signaling research

Forskolin

66575-29-9

Adenylyl cyclase activator that increases cAMP levels

Positive control for Gs-cAMP pathways such as ACTH, TSH, LH/FSH, and GLP-1

cAMP signaling research

IBMX

28822-58-4

Nonselective PDE inhibitor that enhances cAMP signaling

GPCR hormone signaling, cAMP accumulation, and secretion function research

Insulin/IGF signaling research

LY294002

154447-36-6

PI3K inhibitor

Insulin-PI3K/AKT pathway, GLUT4 translocation, and cell survival research

PI3K/AKT signaling research

Wortmannin

19545-26-7

PI3K inhibitor

Dependency validation for insulin, IGF-1, adipokines, and growth signaling

mTOR metabolic signaling research

Rapamycin

53123-88-9

mTOR inhibitor

Insulin nutrient signaling, protein synthesis, lipid metabolism, and autophagy research

Adrenergic signaling research

Isoproterenol hydrochloride

51-30-9

β-adrenergic receptor agonist

cAMP/PKA signaling, lipolysis, cardiovascular responses, and stress responses

Adrenergic signaling research

Propranolol hydrochloride

318-98-9

β-adrenergic receptor antagonist

Sympathetic endocrine signaling, cardiovascular responses, and receptor specificity validation

 

6 Common Questions in Endocrinology and Hormone Research

 

6.1 Does an Increased Hormone Level Always Indicate Endocrine Hyperfunction?

Not necessarily. Increased hormone levels may result from primary hypersecretion, but may also be caused by receptor resistance, weakened negative feedback, changes in binding proteins, drug effects, or reduced clearance. Endocrine hyperfunction should be evaluated together with upstream and downstream hormones as well as target organ function.

 

6.2 Is a Single Hormone Measurement Sufficient to Determine the Disease Mechanism?

In most cases, it is not sufficient. Cortisol, GH, LH, FSH, sex hormones, and melatonin all show rhythmic or pulsatile secretion, so a single measurement is easily affected by sampling time. Mechanistic studies should set appropriate time points, cycle stages, or dynamic tests according to hormone characteristics.

 

6.3 How Should Total Hormones and Free Hormones Be Selected?

Total hormone levels include both protein-bound and free fractions, while free hormone levels are closer to the biologically active state. In studies of thyroid hormones, testosterone, cortisol, and related hormones, changes in binding proteins may affect interpretation of total hormone levels. Therefore, total or free hormone levels should be selected according to the research purpose.

 

6.4 What Are the Most Common Problems in Hormone Detection by ELISA?

Common problems include inappropriate sample dilution, mismatch with the standard curve range, matrix effects, interference from hemolysis or lipemia, antibody cross-reactivity, and excessive freeze-thaw cycles. For low-abundance hormone detection, sensitivity and sample handling should be given particular attention.

 

6.5 Does Increased Hormone Receptor Expression Indicate Enhanced Hormone Action?

Not necessarily. Increased receptor expression only indicates a change in potential responsiveness. The actual hormone effect also depends on ligand concentration, receptor activity, downstream signaling, coregulatory factors, receptor internalization, and target gene expression.

 

Endocrinology and hormone research should integrate hormone source, endocrine axis feedback, receptor expression, downstream signaling, and target organ function. Different hormones vary markedly in structural type, sampling time, detection method, and mechanism of action. Only by correlating hormone levels with functional endpoints can their roles in metabolism, reproduction, stress responses, bone metabolism, and hormone-dependent diseases be interpreted more accurately.

 

For more related articles, please see below:

[1] Endocrine system observation experiment

[2] Gonadotropins: Structural Features, Receptor Signaling, and Research and Application Frameworks

[3] Glucocorticoids: Scientific Overview and Key Application Considerations

[4] JAK-STAT Cell Signaling Pathway

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Applications of Endocrinology/Hormones in Metabolic Regulation, Reproductive Function, and Disease Research》. 阿拉丁知识库,更新于 2026年7月29日。 https://www.aladdin-e.com/zh_cn/faqs/applications-of-endocrinology-hormones-in-metabolic-regulation-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助